Chris Oomen
investor
Chris Oomen is a significant shareholder in Kuros Biosciences, holding nearly a quarter of the company's stock through his investment company Optiver. His involvement is crucial as Kuros navigates its growth trajectory and potential acquisition interests from larger firms like Medtronic.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Chris Oomen is a major shareholder in Kuros, holding nearly a quarter of the shares through Optiver.
6